PERIPHERAL T CELL LYMPHOMA
Clinical trials for PERIPHERAL T CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL T CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for PERIPHERAL T CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for Tough-to-Treat lymphoma
Disease control Not yet recruitingThis study is testing an experimental drug called BR101801 for people with peripheral T-cell lymphoma that has returned or hasn't responded to standard treatments. The trial will enroll 44 participants to see how well the drug shrinks tumors and how safe it is. Patients will take…
Matched conditions: PERIPHERAL T CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo trial offers hope for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis study is testing whether a combination of three targeted drugs (tazemetostat, linperlisib, and golidocitinib) can help control a rare and aggressive blood cancer called peripheral T-cell lymphoma in patients whose disease has returned or not responded to prior treatment. The…
Matched conditions: PERIPHERAL T CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC